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Abstract
Background: Patterns in survival can provide information about the burden and severity of
cancer, help uncover gaps in systemic policy and program delivery, and support the planning of
enhanced cancer control systems. The aim of this paper is to describe the one-year survival rates
for breast cancer in two populations using population-based cancer registries: Ardabil, Iran, and
British Columbia (BC), Canada.
Methods: All newly diagnosed cases of female breast cancer were identified in the Ardabil cancer
registry from 2003 to 2005 and the BC cancer registry for 2003. The International Classification of
Disease for Oncology (ICDO) was used for coding cancer morphology and topography. Survival
time was determined from cancer diagnosis to death. Age-specific one-year survival rates, relative
survival rates and weighted standard errors were calculated using life-tables for each country.
Results: Breast cancer patients in BC had greater one-year survival rates than patients in Ardabil
overall and for each age group under 60.
Conclusion: These findings support the need for breast cancer screening programs (including
regular clinical breast examinations and mammography), public education and awareness regarding
early detection of breast cancer, and education of health care providers.
Background
Despite the extensive knowledge about incidence and sur-
vival rates for cancer in the western world, little informa-
tion is available for the majority of developing countries
[1,2]. International comparisons involving developing
countries are few in number. Where done, survival differ-
ences have been largely attributed to differences in
patient's age, stage of disease at diagnosis, and the pres-
ence of metastasis. Socioeconomic factors, differential
access to health care, insurance status, comorbidities, and
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tolerance to prescribed treament have also been suggested
to determine survival [3-5]. Immigration status and eth-
nicity may also play a role. A study of breast cancer among
ethnic Chinese women reported that those born in East
Asia had lower survival than those born in the US [6]. A
recent study in British Columbia (BC) compared survival
for three cancer sites in Chinese, South Asians and the pre-
dominantly Caucasian general population and found that
Chinese women had the highest survival rates for both
breast and cervical cancer, whereas South Asian women
had the highest rate for colorectal cancer and the lowest
rate for cervical cancer [7].
Patterns in cancer incidence can provide important
insight into the impact of lifestyle upon cancer develop-
ment whereas patterns in survival can provide informa-
tion about the burden and severity of cancer. Identifying
differences in survival between populations can help to
uncover gaps in systemic policy and program delivery,
and support the planning of enhanced cancer control sys-
tems [7]. The aim of this study was to describe one-year
survival rates for breast cancer in two populations using
population-based cancer registries: Ardabil, Iran, and BC,
Canada.
Methods
Study groups
Two groups with established population-based cancer reg-
istries were examined: residents of Ardabil, Iran and BC,
Canada.
Ardabil province, located in the northwestern Iran, is a
mountainous land with an area of nearly 18,000 square
kilometers and a population of 1.1 million persons, 46%
living in urban areas. The Ardabil Cancer Registry (ACR)
was established in 2003 by the Digestive Diseases
Research Center (DDRC) of Tehran University of Medical
Sciences and Ardabil University of Medical Sciences
(ARUMS), with collaboration of the International Agency
for Research on Cancer (IARC). There are 4 kinds of infor-
mation collected by the registry: patient demographics,
tumor characteristics, treatment and patient outcome.
Data are actively collected for newly-diagnosed cancer
cases among permanent residents of Ardabil province.
Patients who are diagnosed in other provinces are cap-
tured in the ACR through sharing of data among Iran's
provinces. All rural residents are covered by a family phy-
sician network and have governmental medical insurance.
Reporting cases of cancer to the ACR is obligatory for fam-
ily physicians. Ardabil's cancer patterns have been studied
since the 1970s [8], its cancer registry is relatively com-
plete, its population is largely homogeneous (98% being
of Azeri ethnicity), and there is minimal immigration into
this area [9].
In contrast, BC, the westernmost province in Canada, has
a land area of nearly 945,000 square kilometers and a
population of about 4 million persons with various ethnic
backgrounds [10]. The provincial cancer registry was
established in 1969, with cancer registration mandated by
law. It has excellent standards of quality control, com-
pleteness of registration and follow-up. It contains per-
sonal and demographic information as well as
information on diagnosis and death of all the cases of can-
cer diagnosed among BC residents (http://www.bccan
cer.bc.ca/HPI/CancerStatistics accessed May 8, 2009). For
BC, there is universal health care and the majority of the
population has geographically accessible cancer treat-
ment.
Data collection
Study population
The International Classification of Disease for Oncology
(ICDO) was used for coding cancer morphology and
topography [11]. All newly diagnosed cases of breast can-
cer (ICDO C50.0-50.9) in women 20 years of age and
older were identified in the Ardabil cancer registry for the
period 2003-2005 and the BC cancer registry for the year
2003. A 3-year period was used in Ardabil because there
are few cases of breast cancer in a single year and statistical
results would be unstable.
Survival time was then determined from cancer diagnosis
to death. In Ardabil province, information on survival sta-
tus and the date of death (if deceased) was collected
directly by interviewing the registered cases or their fami-
lies. In addition, the death registry in Ardabil was used to
confirm the collected information and to gather this data
for registered cases who could not be contacted for inter-
view. Information on the patient's age and date at diagno-
sis, gender and cancer site was obtained from the cancer
registry.
In BC, the survival status of all registered cancer patients is
routinely collected by the cancer registry from govern-
ment vital statistics. Information on the patient's age and
date at diagnosis, gender, cancer site, survival status and
date of death (if deceased) was collected directly from the
cancer registry.
Analysis
Adults were defined as people age 20 years and older. Age-
specific one-year survival rates were calculated for adult
women in the age groups 20-39 years, 40-49 years, 50-59
years and 60+ years. The relative survival rate [12] and a
weighted standard error (SE) were calculated using life-
tables for each country.BMC Cancer 2009, 9:381 http://www.biomedcentral.com/1471-2407/9/381
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Results
Table 1 shows the number of adult women diagnosed
with breast cancer during the study period in Ardabil and
BC, and a one-year survival rate for each age group. Breast
cancer patients in BC had greater one-year survival rates
than patients in Ardabil overall and for each age group
under 60. The median age of breast cancer diagnosis was
61 years (range 24-104 years) in BC and 44 years (range
21-86 years) in Ardabil. About 23% of BC patients and
64% of Ardabil patients were younger than age 50 at the
time of diagnosis. The age-standardized one-year relative
survival rates in BC was 0.99 (SE = 0.004) for adult
women younger than age 50 years and 0.97 (SE = 0.012)
for women age 50 and older. The age-standardized 1-year
relative survival rate in Ardabil was 0.92 (SE = 0.020) for
adult women younger than age 50 and 0.95 (SE = 0.037)
for women age 50 and older.
Discussion
Patterns of cancer incidence and survival vary around the
globe and demographic, ecologic, environmental, cul-
tural, and genetic variables may all contribute to this het-
erogeneity. This first study comparing breast cancer
survival between Iran and BC may contribute to this
understanding. There are clear differences in survival
between these two populations which reflect variations in
severity of cancer, possibly resulting from policy and prac-
tices regarding screening and treatment, cancer biology,
and cancer registration.
Stage of the disease is an important determinant of sur-
vival in patients with breast cancer, but stage is unavaila-
ble in both the Ardabil and BC registries. Based on
experience, we estimate that about 30% of Ardabil
patients and 70% of BC patients are diagnosed at an early
stage of the disease. We hypothesize that the improved
survival observed in BC patients is partly because of this
difference between Ardabil and BC regarding the distribu-
tion of disease stage. One of the reasons for lower survival
rates in Ardabil province may be largely explained by dif-
ferences in screening practices. In BC, a province-wide
screening mammography program was established in
1988. Overall breast cancer survival rates were higher in
BC because of screening mammography and the use of
new adjuvant therapies following surgery for breast cancer
[7,13-16].
Despite current evidence supporting population-based
screening for breast cancer, there is no organized screen-
ing program for breast cancer in Iran. Lack of a screening
program, low awareness of breast cancer, earlier age at
diagnosis, structural barriers to accessing cancer treatment
services, low income and lack of a usual source of care
may all contribute to lower survival from breast cancer in
Iran. We believe that early detection and better manage-
ment using standard screening and treatment guidelines
would contribute considerably to improving survival
from breast cancer in these women. However, the intro-
duction of a population-based breast cancer screening
program or a change in the healthcare system may require
additional information.
Various survival rates for breast cancer have been reported
in the literature among different ethnic populations
[7,17-23]. Asian American women are reported to have
better survival from breast cancer as compared to other
major ethnic minority groups [24]. South Asian women
with breast cancer have inconsistent reports, with better
survival than others in England [25] and California [26]
but worse survival in BC [7].
Hislop reported [7] clear differences in breast cancer sur-
vival among Chinese, South Asian and the BC general
populations. Survival was highest in Chinese women,
Table 1: One -year survival rates for female invasive breast cancer cases diagnosed in 2003 in Ardabil (Iran) and British Columbia 
(Canada) by age group.
Ardabil British Columbia
Age Number of Cases One - year Survival rate Number of Cases One -year Survival rate
20-39 39 0.92 124 0.99
40-49 36 0.92 430 0.99
50-59 27 0.89 597 0.97
60+ 16 1.00 1290 0.92
Total 118 0.92 2441 0.95BMC Cancer 2009, 9:381 http://www.biomedcentral.com/1471-2407/9/381
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which is interesting given that the proportions being
screened were similar among the three ethnic groups.
South Asian women, however, had the poorest survival. It
was speculated that differences in treatment practices and
possibly cancer biology affecting tumor progression may
exist among these ethnic groups. It has been reported that
Asian women with ductal carcinoma in situ of the breast
were more likely to undergo mastectomy than lumpec-
tomy [7,27]), a finding not seen in other groups.
Maskarinc [20] reported that ethnic variations in survival
time among health plan members in Hawaii were not the
result of different treatments, but primarily due to differ-
ences in early detection of breast cancer. When these
investigators examined demographics, disease characteris-
tics, co-morbidity, and treatment patterns, TNM stage was
the strongest predictor of survival and explained the
observed ethnic survival differences.
An earlier Hawaiian study by these investigators [28],
however, had reported that socioeconomic status and
marital status also affected survival in breast cancer
patients. They proposed three possible explanations for
the survival differences: utilization of health services, tol-
erance of treatment, and biologic variations in disease.
Firstly, health services were not equally available to all res-
idents. Many natives lived in remote areas with few health
care providers, and cultural beliefs and practices (incom-
patible with the Western health system) discouraged them
from accepting available health care. Secondly, ethnic dif-
ferences in pre-existing conditions, such as diabetes,
hypertension, obesity, and heart disease, gave some
natives lower tolerance to surgery, chemotherapy, and
radiotherapy, leading to shortened survival. Thirdly, there
may be biologic differences at the genetic or molecular
level resulting in more aggressive disease with faster pro-
gression in some native women as compared to the other
ethnic groups. With a better understanding of the genetic
characteristics of breast cancer, this explanation can be
more fully explored.
Our study has several limitations, including the short fol-
low-up period, giving only a very short-term view of prog-
nosis; the lack of detailed clinical information in the
cancer registries, such as staging and treatment informa-
tion; and the small study population in Ardabil province,
resulting in a relatively large variance. In addition, the
limitations of this study include the shortcomings of Ard-
abil cancer registry as it is newly established. However, the
Ardabil cancer registry covers the entire province. Data are
collected from hospitals, pathology laboratories, diagnos-
tic radiology clinics, outpatient public and private clinics,
death certificate files and an annual health census. The
number of breast cancer cases is low in Ardabil because
the population is small and has a young age-structure. The
relatively young population is particularly important in
our comparison to BC because pre-menopausal breast
cancer patients often have more aggressive disease than
other women. Furthermore, Ardabil has one of the lowest
breast cancer incidence rates in the world; gastric and
esophageal cancers are the most-common forms of cancer
in Ardabil. This might be the result of women's late age at
menarche, reproductive behaviors and increased breast-
feeding (as part of religious beliefs). Our analyses
assumed that patients from both registries were still living
after 1 year if no death was reported, although this
assumption depends largely on the sources of informa-
tion regarding deaths in the respective populations. In any
population, it is difficult to know whether a patient's
death is due to their breast cancer. This issue is particularly
relevant in a comparison of populations with very differ-
ent healthcare systems. Our analysis concerns the overall
mortality of breast cancer patients, although the causes of
death and the veracity of reported causes might be sub-
stantially different in Ardabil and BC. Although the cases
were diagnosed in 2003, we could not extend the length
of follow-up beyond one year because survival data was
only available in BC to the end of 2004.
There is need for interventions that specifically target
women with low education. Fear and embarrassment con-
tribute to the lack of use of screening services and breast
self examination. To better understand these issues, and
how screening and treatment decisions are made, qualita-
tive information should be collected from breast cancer
patients and their health care providers.
Community intervention programs aimed at better under-
standing known risk factors of breast cancer, healthy life-
style, and the importance of early detection are needed to
help reduce deaths from breast cancer. These educational
sessions should also provide information on how to get a
mammogram and the steps to take following a diagnosis
of breast cancer.
In both Ardabil province and BC, there is ongoing need
for public education and awareness regarding early detec-
tion of breast cancer. This requires the use of communica-
tion media such as radio and television advertisements
and programs for a mass education program. In addition
to educating the public, it is also important to educate
health care providers, especially those with whom are
most likely to have contact. There is a need for establish-
ment and implementation of screening programs for
breast cancer, including regular breast examination, clini-
cal breast exam and mammography, so that early lesions
can be detected with a better survival and reduction of
mortality. However, the introduction of a population-
based breast cancer screening program or a change in the
healthcare system may require additional information.BMC Cancer 2009, 9:381 http://www.biomedcentral.com/1471-2407/9/381
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Continued research into the causes of the disease, its pre-
vention and improved methods of detection and treat-
ment are essential if we are to make inroads into the
control of this important cancer on a global scale.
Conclusion
Breast cancer patients in BC had greater one-year survival
rates than patients in Ardabil overall and for each age
group under 60. These findings support the need for
breast cancer screening programs (including regular clini-
cal breast examinations and mammography), public edu-
cation and awareness regarding early detection of breast
cancer, and education of health care providers
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